SQBB - Taisho Pharmaceutical Indonesia Tbk
Margin Laba Kotor vs Margin Laba Operasi vs Margin Laba Bersih
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Margin Laba Kotor | |||||||
| Margin Laba Operasi | |||||||
| Margin Laba Bersih |
Imbal Hasil Aset vs Imbal Hasil Ekuitas
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Imbal Hasil Aset | |||||||
| Imbal Hasil Ekuitas |
Margin Laba Kotor
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Margin Laba Kotor | |||||||
| Sektor |
167,95
-
|
34,31
79,57%
|
171,07
398,66%
|
155,12
9,32%
|
78,52
49,38%
|
44,72
43,04%
|
-
-
|
Margin Laba Operasi
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Margin Laba Operasi | |||||||
| Sektor |
42,62
-
|
9,05
78,77%
|
43,95
385,77%
|
44,88
2,13%
|
21,14
52,89%
|
-0,35
101,64%
|
7,40
2.228,37%
|
Margin Laba Bersih
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Margin Laba Bersih | |||||||
| Sektor |
8,49
-
|
1,17
86,21%
|
0,74
36,50%
|
-2,46
430,21%
|
-0,04
98,20%
|
-9,50
21.418,88%
|
5
152,64%
|
Imbal Hasil Aset
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Imbal Hasil Aset | |||||||
| Sektor |
5,44
-
|
6,04
10,93%
|
5,28
12,56%
|
5,53
4,69%
|
6
8,47%
|
3,97
33,76%
|
3,38
14,98%
|
Imbal Hasil Ekuitas
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
| Imbal Hasil Ekuitas | |||||||
| Sektor |
14,18
-
|
11,99
15,46%
|
8,96
25,26%
|
10,32
15,12%
|
6,65
35,53%
|
5,08
23,56%
|
10,08
98,21%
|
Anda dapat melakukan login jika ingin melihat data historis yang lebih panjang. Belum punya login? Yuk mari bergabung.